NCT00563758View on ClinicalTrials.gov

A Randomized, Double-blind, Placebo-controlled Multicenter Study to Assess the Efficacy, Safety and Tolerability of Tegaserod 2 mg Bid vs Placebo in Patients With Chronic Constipation

NATerminatedINTERVENTIONAL

Enrollment

250

Participants

Timeline

Start Date

December 31, 2004

Study Completion Date

February 28, 2006

Conditions

ConstipationChronic Disease

Interventions

DRUG

tegaserod

Trial Locations (1)

Unknown

Queen Mary Hospital, Hong Kong

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Novartis

INDUSTRY

lead

Hospital Authority, Hong Kong

OTHER_GOV